Study Details Controlled Study of Immunogenicity and safety of the Investigational vYF candidate vaccine in comparison to Stamaril in Adults
Protocol Number VYF03
Phase II
Therapeutic Area Infectious Diseases
Subject Types Healthy volunteer
Indication Yellow fever
Principal Investigator Prof Paul Anantharajah Tambyah
Investigator Product / Device vYF
Sponsor Sanofi-Aventis Singapore Pte Ltd
Top